Retrospective analysis of patients with relapsed/refractory medulloblastoma after autologous stem cell transplantation
Journal Title: Gulhane Medical Journal - Year 2020, Vol 62, Issue 4
Abstract
Aims: Medulloblastoma is very rare and accounts for only 1% of intracranial tumors in adults. There are limited treatment options for adult medulloblastoma patients who have relapsed or refractory disease. We aimed to show real-life data on health outcomes in adult patients with recurrent or refractory medulloblastoma patients who received autologous hematopoietic stem cell transplantation (AHSCT). Methods: We analyzed the data of 15 patients who underwent AHSCT after ifosfamide, carboplatin, and etoposide (ICE) as high-dose chemotherapy (HDCT) regimen for relapsed or refractory medulloblastoma from 2010 to 2020. Overall response rate (ORR), overall survival (OS) and progression-free survival (PFS) of the patients were evaluated. Results: Fifteen patients were observed in this study. The mean age of the study group was 27.9±8.1 years and 53.3% of the patients were female (n=8). ORR was 100%. The median OS and PFS were 24 months [95% confidence interval (CI): 11.4-36.5] and 13 months (95% CI: 10.2-15.8), respectively. One-year OS and PFS rates were 77% and 55.2%, respectively. Five-year OS rate was 82.5%. Conclusions: AHSCT with ICE as HDCT regimen is a safe and effective treatment option for relapsed or refractory adult medulloblastoma patients with an acceptable ORR, OS and PFS time.
Authors and Affiliations
Ramazan Acar, İsmail Ertürk, Halil Kızılöz, Sezgin Okçelik, Birol Yıldız, Musa Barış Aykan, Gül Sema Yıldıran Keskin, Erdim Sertoğlu, Bilgin Bahadır Başgöz, Nuri Karadurmuş
Assessment of mandibular buccal shelf for an ideal miniscrew implantation site using cone-beam computed Tomography
Aims: The aim of the study was to evaluate the cortical bone thickness and bone width of the buccal shelf area and to determine the optimal sites for mini screw-implant placement. Methods: In this retrospective study, c...
Does the efficacy of different doses of Botulinum neurotoxin in chronic migraine change in terms of age and sex?
Aim: The aim of this study was to investigate the effectiveness of Botulinum toxin A (BoNTA) treatment at different doses according to age and sex. Methods: In this study, 53 patients diagnosed as chronic migraine (CM)...
Complementary and alternative medicine usage in patients with Familial Mediterranean Fever
Aims: Colchicine is mainstay in the treatment of Familial Mediterranean Fever (FMF). In chronic diseases, complementary and alternative medicine (CAM) methods can be chosen as a non-mainstream treatment. We aimed to iden...
A rare case of multiple fibro-folliculomas and lung cysts: Possible Birt-Hogg-Dube syndrome
Birt-Hogg-Dubè syndrome (BHD) is an autosomal-dominant syndrome, which is very rare to come across with in clinical practice. The disease demonstrates itself with multiple skin hamartomas, multiple fiber-folliculomas, an...
The awareness of chronic obstructive pulmonary disease among smokers admitting to pulmonary medicine outpatient clinic: Single center experience
Aims: Smoking is the strongest risk factor for chronic obstructive pulmonary disease (COPD), but the awareness of COPD among smokers has been found at low levels worldwide. The aim of current study was to assess the COPD...